1995JAMARequires access

Fluoxetine and Sexual Dysfunction-Reply

Jay B. Hollander

Open publisher page 1 citations

Abstract

In Reply. —Since my answer to the question of fluoxetine and sexual dysfunction, JAMA has received numerous letters disputing my statement that sexual dysfunction occurs in up to 1.9% of patients. I wish that I could claim a typing error, but I chose to quote the Physicians' Desk Reference in search of a rate of sexual dysfunction to explain the patient's delayed orgasm. Clearly, the rate of delayed ejaculation or anorgasmia is much higher than 1.9%. Indeed, drugs that inhibit serotonin reuptake may have a therapeutic effect in patients with premature ejaculation. At this time, the letters I have received from JAMA quote rates of 7.8% to 75% of patients having problems with sexual dysfunction. 1,2 Many articles address overall sexual dysfunction, including anorgasmia in patients receiving fluoxetine, but careful perusal shows small numbers of men studied. Zajecka et al 1 suggest a 7.8% incidence of sexual dysfunction in men

About this research paper

What this paper is about

In Reply. —Since my answer to the question of fluoxetine and sexual dysfunction, JAMA has received numerous letters disputing my statement that sexual dysfunction occurs in up to 1.9% of patients. I wish that I could claim a typing error, but I chose to quote the Physicians' Desk Reference in search of a rate of sexual dysfunction to explain the patient's delayed orgasm. Clearly, the rate of delayed ejaculation or anorgasmia is much higher than 1.9%. Indeed, drugs that inhibit serotonin reuptake may have a therapeutic effect in patients with premature ejaculation. At this time, the letters I have received from JAMA quote rates of 7.8% to 75% of patients having problems with sexual dysfunction. 1,2 Many articles address overall sexual dysfunction, including anorgasmia in patients receiving fluoxetine, but careful perusal shows small numbers of men studied. Zajecka et al 1 suggest a 7.8% incidence of sexual dysfunction in men

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Reply. —Since my answer to the question of fluoxetine and sexual dysfunction, JAMA has received numerous letters disputing my statement that sexual dysfunction occurs in up to 1.9% of patients. I wish that I could claim a typing error, but I chose to quote the Physicians' Desk Reference in search of a rate of sexual dysfunction to explain the patient's delayed orgasm. Clearly, the rate of delayed ejaculation or anorgasmia is much higher than 1.9%. Indeed, drugs that inhibit serotonin reuptake may have a therapeutic effect in patients with premature ejaculation. At this time, the letters I have received from JAMA quote rates of 7.8% to 75% of patients having problems with sexual dysfunction. 1,2 Many articles address overall sexual dysfunction, including anorgasmia in patients receiving fluoxetine, but careful perusal shows small numbers of men studied. Zajecka et al 1 suggest a 7.8% incidence of sexual dysfunction in men

Key concepts: Medicine, Fluoxetine, Sexual dysfunction, Psychiatry, Internal medicine, Serotonin, Receptor

Related papers

Back to paper searchBrowse research topicsOriginal source
Fluoxetine and Sexual Dysfunction-Reply — Research Paper | ScholarLens